Christian Simhandl1, Joaquim Radua2, Barbara König1, Benedikt L Amann3. 1. Bipolar Center Wiener Neustadt, Bahngasse 43, A-2700 Wiener Neustadt, Austria. 2. FIDMAG Research Foundation Germanes Hospitaláries, Barcelona, Spain; CIBERSAM, Madrid, Spain. 3. FIDMAG Research Foundation Germanes Hospitaláries, Barcelona, Spain; CIBERSAM, Madrid, Spain. Electronic address: benedikt.amann@gmail.com.
Abstract
BACKGROUND: Life events may very well increase the likelihood of affective episodes in bipolar disorder, but prospective data on survival are inconsistent. METHODS: The authors examined the prevalence of negative and goal-attainment life events within 6 months prior to the index episode and after the index episode and their impact on the risk of relapse. Two hundred twenty-two consecutively admitted ICD-10 bipolar I (n=126) and II (n=96) patients were followed-up naturalistically over a period of 4 years. RESULTS: One-hundred thirty-eight (62.2%) of the patients had at least one life event 6 month before the index episode. Seventy patients (31.5%) experienced one, 48 (21.6%) two, and 20 (9.0%) three (or more) life events. Regarding life events after the index episode, 110 (49.5%) patients had at least one life event. Fifty-four patients (24.3%) experienced one, 31 (14.0%) two, and 25 (11.3%) three (or more) life events. The number of life events was larger in patients with bipolar II disorder than in patients with bipolar I disorder (p=0.004). Using a Cox regression analysis, the risk of a depressive relapse in bipolar I patients was associated with the number of life events after the index episode (p=0.002). This was independent of the quality of the life event. LIMITATIONS: Standardized life event scales, defined dosages of drugs or blood sampling during all visits were not performed. CONCLUSIONS: Our data suggest a high and continuous number of life events prior to affective episodes. Life events after the index episode worsened the course of bipolar I patients with more depressive episodes. This underlines the importance of detection and treatment of emerging life events.
BACKGROUND: Life events may very well increase the likelihood of affective episodes in bipolar disorder, but prospective data on survival are inconsistent. METHODS: The authors examined the prevalence of negative and goal-attainment life events within 6 months prior to the index episode and after the index episode and their impact on the risk of relapse. Two hundred twenty-two consecutively admitted ICD-10 bipolar I (n=126) and II (n=96) patients were followed-up naturalistically over a period of 4 years. RESULTS: One-hundred thirty-eight (62.2%) of the patients had at least one life event 6 month before the index episode. Seventy patients (31.5%) experienced one, 48 (21.6%) two, and 20 (9.0%) three (or more) life events. Regarding life events after the index episode, 110 (49.5%) patients had at least one life event. Fifty-four patients (24.3%) experienced one, 31 (14.0%) two, and 25 (11.3%) three (or more) life events. The number of life events was larger in patients with bipolar II disorder than in patients with bipolar I disorder (p=0.004). Using a Cox regression analysis, the risk of a depressive relapse in bipolar Ipatients was associated with the number of life events after the index episode (p=0.002). This was independent of the quality of the life event. LIMITATIONS: Standardized life event scales, defined dosages of drugs or blood sampling during all visits were not performed. CONCLUSIONS: Our data suggest a high and continuous number of life events prior to affective episodes. Life events after the index episode worsened the course of bipolar Ipatients with more depressive episodes. This underlines the importance of detection and treatment of emerging life events.
Authors: Ana Moreno-Alcázar; Joaquim Radua; Ramon Landín-Romero; Laura Blanco; Mercè Madre; Maria Reinares; Mercè Comes; Esther Jiménez; Jose Manuel Crespo; Eduard Vieta; Victor Pérez; Patricia Novo; Marta Doñate; Romina Cortizo; Alicia Valiente-Gómez; Walter Lupo; Peter J McKenna; Edith Pomarol-Clotet; Benedikt L Amann Journal: Trials Date: 2017-04-04 Impact factor: 2.279
Authors: Chiara Buizza; Valentina Candini; Clarissa Ferrari; Alberto Ghilardi; Francesco Maria Saviotti; Cesare Turrina; Gianluigi Nobili; Margherita Sabaudo; Giovanni de Girolamo Journal: Front Psychiatry Date: 2019-11-26 Impact factor: 4.157
Authors: Anna Wrobel; Samantha E Russell; Olivia M Dean; Sue Cotton; Michael Berk; Alyna Turner Journal: BMJ Open Date: 2021-04-29 Impact factor: 2.692